Drug intelligence / Profile preview

bay k 8644

Development stage
Preclinical
Lead developer
Bayer
Modality
Small Molecules
Administration
Experimental (common: Parenteral Injection In Research, Not Approved For Therapeutic Human Administration)[3]
01

Overview

**BAY K 8644** is a synthetic small molecule, structurally related to dihydropyridine calcium channel blockers, and functions as an **L-type voltage-gated calcium channel agonist** (specifically, an activator), though it can also exert antagonist/blocking properties in a use- and voltage-dependent manner. It is widely used as a biochemical and pharmacological tool to study the physiology and pharmacology of calcium currents, especially in cardiac and neuronal cells. BAY K 8644 has positive inotropic and vasoconstrictive effects in animal models and can modulate hormone secretion by enhancing calcium-dependent exocytosis. Its behavioral and in vivo cardiovascular effects are dose- and enantiomer-dependent[2][3][4][5][6][7].

Other names
methyl 2,6-dimethyl-5-nitro-4-[2-(trifluoromethyl)phenyl]-1,4-dihydropyridine-3-carboxylate(+/-)-BAY K 8644Bay K8644
02

Targets

CACNA1C (Voltage-dependent L-type calcium channel subunit alpha-1C)

Beyond the preview

Go deeper on bay k 8644.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on bay k 8644.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call